Portside Wealth Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Buy |
3,198
+253
| +9% | +$113K | 0.21% | 107 |
|
|
2025
Q1 | $1.43M | Buy |
2,945
+679
| +30% | +$329K | 0.23% | 102 |
|
|
2024
Q4 | $913K | Buy |
2,266
+261
| +13% | +$105K | 0.15% | 148 |
|
|
2024
Q3 | $932K | Buy |
2,005
+193
| +11% | +$89.8K | 0.16% | 146 |
|
|
2024
Q2 | $849K | Buy |
1,812
+30
| +2% | +$14.1K | 0.16% | 142 |
|
|
2024
Q1 | $745K | Buy |
1,782
+126
| +8% | +$52.7K | 0.14% | 161 |
|
|
2023
Q4 | $674K | Buy |
1,656
+144
| +10% | +$58.6K | 0.13% | 176 |
|
|
2023
Q3 | $522K | Buy |
1,512
+226
| +18% | +$78K | 0.1% | 189 |
|
|
2023
Q2 | $453K | Buy |
+1,286
| New | +$453K | 0.08% | 208 |
|